The effect of inhibiting hindbrain A2 noradrenergic neurons by 6-Hydroxydopamine on lipopolysaccharide-treated male rats autistic animal model
Authors:
- Hussain N. AlhamamiHAHussain N. Alhamami
- Abdullah M. AlbogamiAAAbdullah M. Albogami
- Mohammad M. AlgahtaniMAMohammad M. Algahtani
- Mohammed AlqinyahMAMohammed Alqinyah
- Wael A. AlanaziWAWael A. Alanazi
- Fawaz AlasmariFawaz Alasmari
- Khalid AlhazzaniKAKhalid Alhazzani
- Ahmed Z. AlanaziAAAhmed Z. Alanazi
- Yasseen A. AlassmrryYAYasseen A. Alassmrry
- Abdullah S. AlhamedAAAbdullah S. Alhamed
Open Access
- 1 March 2024
- journal article
- research article
- Published by Springer Nature in Saudi Pharmaceutical Journal
- Vol. 32 (3) , 101964
Abstract
Autism spectrum disorder (ASD) is a complex neurodevelopmental illness that often emerges in early childhood. The incidence of ASD has shown a notable rise in recent years. ASD is defined by deficits in social communication, and presence of rigid and repetitive behaviors and interests. The underlying mechanisms of ASD remain elusive. Multiple studies have documented the presence of neuroinflammation and increased levels of inflammatory cytokines, specifically, IL-6, TNF, and NF-κB, in various brain regions, including the prefrontal cortex (PFC) and hippocampus in individuals with ASD. Noradrenergic neurons play a crucial role in brain development and the regulation of motor, behavioral, and memory functions. This study sought to examine the impact of intracerebroventricular (icv.) injection of the neurotoxin, 6-hydroxydopamine (6-OHDA), in the caudal dorsal vagal complex A2 neurons on various neuroinflammatory pathways at the hippocampus and PFC in valproic acid (VPA) autistic animal model. This was done in conjunction with an intraperitoneal (i.p.) injection of Lipopolysaccharides (LPS) in animal models with VPA-induced autism. We specifically examined the impact of the caudal fourth ventricle 6-OHDA icv. injection and LPS (i.p.) injection on self-grooming behavior. We measured the mRNA expression of IL-6, TNF-a, and NF-κB using qRT-PCR, and the protein expression of COX-2, GPX-1, p-AMPK, and AMPK using western blot analysis. The self-grooming activity was considerably higher in the combined treatment group (6-OHDA icv. + LPS i.p.) compared to the control group. A substantial increase observed in the expression of IL-6, TNF-α, and NF-κB genes in the PFC of the treatment group that received icv. Administration of 6-OHDA, compared to the control group. The VPA-autism rats that received the combo treatment exhibited a slight increase in the expression level of NF-κB gene in the hippocampus, compared to the control group. At the PFC, we noticed a substantial drop in the expression of the antioxidant protein GPX-1 in the group that received the combo treatment compared to the control group. Our data investigates a novel aspect that the 6-OHDA-induced inhibition of hindbrain A2 neurons could be influencing the neuroinflammatory pathways in the PFC and hippocampus of autistic animal models.Keywords
Funding Information
- King Saud University
This publication has 60 references indexed in Scilit:
- Celecoxib reduces brain dopaminergic neuronaldysfunction, and improves sensorimotor behavioral performance in neonatal rats exposed to systemic lipopolysaccharideJournal of Neuroinflammation, 2013
- IL-6 is increased in the cerebellum of autistic brain and alters neural cell adhesion, migration and synaptic formationJournal of Neuroinflammation, 2011
- Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functionsAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2011
- Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's diseaseBrain Research, 2010
- The Neurobiology of Lipid Metabolism in Autism Spectrum DisordersNeurosignals, 2010
- Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegenerationInternational Journal of Neuropsychopharmacology, 2008
- Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's diseaseBrain, 2008
- Bilobalide inhibits 6-OHDA-induced activation of NF-κB and loss of dopaminergic neurons in rat substantia nigraActa Pharmacologica Sinica, 2008
- Neuroinflammation mediated by IL-1β increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's diseaseJournal of Neuroinflammation, 2008
- Lentivirus-mediated expression of glutathione peroxidase: Neuroprotection in murine models of Parkinson's diseaseNeurobiology of Disease, 2006